2/23
08:01 am
rnaz
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
Low
Report
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
2/5
08:46 am
rnaz
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138 [Yahoo! Finance]
High
Report
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138 [Yahoo! Finance]
2/5
08:04 am
rnaz
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
High
Report
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
1/24
05:10 am
rnaz
TransCode Therapeutics (NASDAQ:RNAZ) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
TransCode Therapeutics (NASDAQ:RNAZ) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/6
08:37 am
rnaz
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma [Yahoo! Finance]
Medium
Report
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma [Yahoo! Finance]
1/6
08:01 am
rnaz
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
Medium
Report
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
12/22
08:39 am
rnaz
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors [Yahoo! Finance]
Medium
Report
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors [Yahoo! Finance]
12/22
08:01 am
rnaz
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors
Medium
Report
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors
12/11
08:05 am
rnaz
TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trial
High
Report
TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trial